Ok
Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain
New analyses suggest Adagio Therapeutics' Covid antibody could still tackle the omicron variant — and ADGI stock soared on Thursday.
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
3
举报
登录后可参与评论
![empty](https://c1.itigergrowtha.com/community/assets/media/empty-default.06ba11e0.png)
暂无评论